BIOGEN INC (BIIB)
US09062X1037 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.05B | 3.42B | 2.26B | 1.33B | 2.91B | |||
| Marketable Securities | 0.00 | 1.47B | 1.54B | 1.28B | 1.56B | |||
| Receivables | 2.10B | 2.14B | 1.96B | 2.33B | 2.47B | |||
| Inventories | 2.53B | 1.34B | 1.35B | 1.07B | 804.00M | |||
| Other Current Assets | 1.18B | 1.42B | 741.00M | 881.00M | 631.00M | |||
| Total Current Assets | 6.86B | 9.79B | 7.86B | 6.89B | 8.38B | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.73B | 3.70B | 3.79B | 3.85B | 3.67B | |||
| Investments And Advances | 745.00M | 2.23B | 2.83B | 3.67B | 2.65B | |||
| Goodwill | 6.22B | 5.75B | 5.76B | 5.76B | 5.76B | |||
| Intangibles | 8.36B | 1.85B | 2.22B | 3.08B | 3.53B | |||
| Other Non-Current Assets | 928.60M | 1.23B | 1.42B | 1.37B | 3.24B | |||
| Total Non-Current Assets | 19.99B | 14.76B | 16.02B | 17.73B | 18.85B | |||
| TOTAL ASSETS | 26.84B | 24.55B | 23.88B | 24.62B | 27.23B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 150.00M | 0.00 | 999.00M | 0.00 | 1.50B | |||
| Accrued Expenses | 1.66B | 1.59B | 1.47B | 1.72B | 1.68B | |||
| Accounts Payable | 403.30M | 492.00M | 589.00M | 455.00M | 531.00M | |||
| Other Current Liabilities | 1.22B | 1.19B | 1.24B | 1.57B | 1.16B | |||
| Total Current Liabilities | 3.43B | 3.27B | 4.30B | 3.74B | 4.86B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 6.79B | 6.28B | 6.27B | 7.43B | 4.46B | |||
| Deferred Taxes/Income | 641.80M | 335.00M | 695.00M | 1.03B | 2.81B | |||
| Other Non-Current Liabilities | 1.18B | 1.28B | 1.65B | 1.73B | 1.76B | |||
| Total Non-Current Liabilities | 8.61B | 7.88B | 8.68B | 10.18B | 9.03B | |||
| TOTAL LIABILITIES | 12.05B | 11.16B | 12.98B | 13.92B | 13.89B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 17.63B | 16.47B | 13.91B | 13.98B | 16.45B | |||
| Additional Paid In Capital | 302.50M | 73.00M | 68.00M | 0.00 | 0.00 | |||
| Minority Interest | -400.00K | 75.00M | -108.00M | -74.00M | -4.00M | |||
| Common Shares | 100.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -2.98B | -2.98B | -2.98B | -2.98B | -2.98B | |||
| Other Shareholders' Equity | -153.70M | -149.00M | -105.00M | -300.00M | -139.00M | |||
| Shares Outstanding | 144.90M | 144.00M | 147.00M | 152.00M | 174.00M | |||
| Tangible Book Value per Share | 1.50 | 40.27 | 19.82 | 12.20 | 23.32 | |||
| Total Shareholders' Equity | 14.80B | 13.40B | 10.90B | 10.70B | 13.34B | |||
| TOTAL LIABILITIES AND EQUITY | 26.84B | 24.55B | 23.88B | 24.62B | 27.23B | |||
| Statistics | ||||||||
| Debt/Equity | 0.46 | 0.47 | 0.58 | 0.69 | 0.33 | |||
| Current Ratio | 2.00 | 2.99 | 1.83 | 1.84 | 1.72 | |||
| Return On Assets (ROA) | 4.33% | 12.41% | 6.52% | 16.25% | 21.62% | |||
| Return On Equity (ROE) | 7.85% | 22.74% | 14.28% | 37.39% | 44.14% | |||
| Return On Invested Capital (ROIC) | 7.53% | 13.02% | 15.35% | 20.49% | 29.05% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 7.88% | 16.91% | 19.04% | 23.41% | 36.31% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 22.66% | 31.54% | 38.55% | 45.40% | 75.48% | |||
All data in USD